Happy Health partnership aims to reduce barriers to care by putting patients in control of their own health journey and enabling nightly monitoring to enhance early stage detection using the Happy Ring and Happy Sleep platform, powered by EnsoData’s EnsoSleep PPG AI algorithm for scoring and analysis of the sleep data.
EnsoData Announcements
Scroll below to find recent press releases around EnsoData’s FDA clearances, partnerships, research, fundraising, milestones, awards, and other noteworthy recognition
EnsoData and Nonin partner to offer affordable, non-invasive at home sleep testing for patients at risk of sleep apnea, bringing accessible sleep testing and diagnosis to all audiences, including patients with limited access to care
EnsoData adds acoustic flow and microphone data channels to enable an exciting new way to pre-screen patients for sleep apnea, allowing EnsoData to improve access and affordability in underserved sleep apnea patient populations.
Partnership Announcement: AI software integration between EnsoData and Parachute Health aims to connect sleep disorder diagnosis to therapy prescription.
Aeroflow and EnsoData usher in a new era in personalized sleep apnea care, population health management, and patient coaching with AI-powered predictive analysis of CPAP monitoring data.
EnsoData announces its FDA-cleared diagnostic AI analysis and sleep scoring solution, EnsoSleep, earned stage-specific autoscoring software certification from the American Academy of Sleep Medicine (AASM).
EnsoData achieved FDA 510(k) clearance for groundbreaking technology that enables AI-powered sleep diagnosis using FDA-cleared pulse oximetry (pulse ox) devices.
EnsoData and React Health announced a strategic collaboration to optimize PAP adherence support for patients with sleep apnea using EnsoData’s AI technology.
EnsoData Ranks Among Highest-Scoring Businesses on Inc. Magazine’s 2023 List of Best Workplaces, marking third consecutive year on the list.
EnsoData Applies AI to Address Health Concerns for 1,000,000 Patients Worldwide, a milestone reached in May 2023.
EnsoData has appointed Dr. Nathaniel Watson as New Chief Medical Officer, expanding its clinical sleep expertise.
EnsoData’s new funding, coupled with new partnerships and an executive hire, promise rapid growth and accelerated delivery of its validated AI solution for sleep medicine.
EnsoData in the Press
EnsoData and HappyHealth, manufacturers of the Happy Ring, announce a partnership to meet the growing demand for simple, clinical-grade nightly sleep monitoring in the home. Happy Health’s platform, Happy Sleep, allows patients to directly receive an FDA-approved sleep test powered by EnsoSleep PPG, see a board-certified sleep doctor, and begin personalized care with continuous monitoring,…
Summary: Happy Health and EnsoData have partnered to offer an at-home solution for diagnosing sleep apnea through the wearable Happy Ring.
A dearth of data makes it difficult for the HME industry to fully leverage AI and other developing technologies, so it may have to shift its focus, according to a panel of vendors at the HME News Business Summit in October. Because personal health information is protected and because HME companies are typically smaller in…
Happy Health’s platform, Happy Sleep, now allows patients to directly receive an FDA-approved sleep test powered by EnsoData PPG, see a board-certified sleep doctor and begin personalized care – all from the comfort of their homes and all in just three days
EnsoData’s Sleep AI reaches Cardiology and Pulmonology – EnsoData’s Sleep AI has diagnosed 1.5M patients, monitors 150K patients on therapy, and streamlines care for 1-in-10 US Sleep Apnea patients. Now, we’re launching AI capabilities to break down care silos across Sleep, Cardiac, and Pulmonary care delivery.
EnsoData, Nonin Partner to Offer Affordable Home Sleep Apnea Testing Read more: https://sleepworldmagazine.com/2024/08/28/ensodata-nonin-partner-to-offer-affordable-home-sleep-apnea-testing/
EnsoData, Nonin partner to increase access to home sleep testing A new partnership will combine the EnsoSleep PPG software as a medical device (SaMD) algorithm with Nonin’s WristOx Model 3150 reusable wrist-worn device to offer sleep labs an affordable solution to test for sleep apnea at home.
EnsoData and Nonin Partner to Offer Sleep Labs New Home Sleep Testing Solution The new collaboration integrates EnsoData’s FDA-cleared AI software with Nonin’s wearable pulse oximeter for at-home sleep apnea testing.
More exciting, from my point of view, is how technology empowers patients. Editor Liz spoke with Sam Rusk at EnsoData about that company’s recent partnership with Aeroflow Health (see page 1) to use its predictive tools to identify patients struggling with therapy. By looking at data that includes everything from leaks to AHI, its technology…
EnsoData has acquired sleep testing diagnostic technology from Resonea, adding acoustic flow and microphone data channels to its platform as a new way to use a mobile application to pre-screen patients for sleep apnea and extend the diagnostic capabilities of home sleep testing
Multimedia
The below gallery includes photos for use by members of the media. For press inquiries or to reach out to our EnsoData team to schedule an interview, podcast guest, or with any other general inquiries at team@ensodata.com.
EnsoData Leadership Team Bios
“Be thoughtful, be mindful, and take your time in situations where bias could be present.”
Andrea Ramberg, RPSGT, CCSH EnsoData Clinical Director
Stay Up to Date
Learn More about EnsoSleep and Get Our Resources Delivered Straight to Your Inbox
"*" indicates required fields